Investment
Features
FeesSafety
Academy
More
Pluang+

DXC Technology names Jonathan Nikols President of Americas Market to boost sales and AI growth.

Market News
18 Sep 2026
PRNewsWire
View Source
Bullish
DXC Technology names Jonathan Nikols President of Americas Market to boost sales and AI growth.

DXC Technology appointed Jonathan Nikols as President of the Americas Market to lead sales across North, Central, and South America. Nikols brings over 25 years of experience in technology sales and will focus on strengthening sales execution, improving customer engagement, and accelerating AI-driven growth. This leadership change aims to enhance DXC's commercial discipline and help customers modernize and leverage AI for better business outcomes. Rick Ruiz will continue leading U.S. Public Sector and Canada territories under Nikols' oversight.

DXC Technology's leadership update is the subject, with Pluang's Technology sector market data provided for context. For readers following technology stocks, here is Pluang's market snapshot as of Sep 18, 2026 18:51 WIB: out of 150 priced US tech stocks, 71 rose and 71 fell. Notable movers include AXTI at USD 68.78 (+1.52%), LOGI at USD 104.00 (+1.42%), and CIFR at USD 17.18 (+1.42%).

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
1 hour ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
2 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
2 hours ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
3 hours ago
India's gold demand stays strong despite price swings; ETF inflows and futures trading rise in August.

India's gold demand stays strong despite price swings; ETF inflows and futures trading rise in August.

In August, India's gold market showed resilience with steady jewelry buying and physical investment demand despite volatile gold prices. Domestic gold prices rose 12% in August but pulled back in September amid changing Fed policy expectations. Gold ...

Market News
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App